Literature DB >> 29505680

Impact of hemophilia B on quality of life in affected men, women, and caregivers-Assessment of patient-reported outcomes in the B-HERO-S study.

Tyler W Buckner1, Michelle Witkop2, Christine Guelcher3, Robert Sidonio4, Craig M Kessler5, David B Clark6, Wendy Owens7, Neil Frick8, Neeraj N Iyer9, David L Cooper9.   

Abstract

INTRODUCTION: Health-related quality of life (HRQoL) is impaired in patients with hemophilia; however, the impact in mild/moderate hemophilia B and affected women is not well characterized.
OBJECTIVE: To evaluate factors that affect HRQoL in adults with hemophilia B and caregivers of affected children.
METHODS: US adult patients and caregivers of affected children completed distinct ~1-hour online surveys including patient-reported outcome instruments.
RESULTS: In total, 299 adult patients and 150 caregivers participated. Adults with moderate hemophilia reported poorer health status (median EQ-5D-5L index score, 0.63) than those with mild (0.73) or severe (0.74) hemophilia. Women reported greater pain severity than men on the Brief Pain Inventory v2 Short Form (median, 7.00 vs 5.00). Based on the Patient Health Questionnaire, mild or worse depression was observed in >50% of adult respondents, and depression was reported more often in those with moderate and severe hemophilia vs those with mild hemophilia. Most caregivers reported at least mild depression.
CONCLUSION: Pain, functional impairment, and depression/anxiety are present at higher-than-expected levels in individuals with hemophilia B. The large proportion of individuals with mild/moderate hemophilia and women with reduced health status suggests significant unmet needs in this population.
© 2018 The Authors. European Journal of Haematology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  anxiety; caregivers; depression; functional impairment; hemophilia B; pain; patient-reported outcomes; quality of life

Mesh:

Year:  2018        PMID: 29505680     DOI: 10.1111/ejh.13055

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  10 in total

1.  Health care resource utilization and cost burden of hemophilia B in the United States.

Authors:  Tyler W Buckner; Iryna Bocharova; Kaitlin Hagan; Arielle G Bensimon; Hongbo Yang; Eric Q Wu; Eileen K Sawyer; Nanxin Li
Journal:  Blood Adv       Date:  2021-04-13

2.  Investigation of the Bleeding Tendency in Sudanese Female Carriers of Hemophilia B.

Authors:  Ismail Ali Abdallah Abker; Salaheldein G Elzaki; Salih Abdelgader Elmahdi; Jowaria Eltayeb Tayrab; Samia Mahdi Ahmed; Eltayeb Tayrab
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

3.  Efficacy of EHL N9-GP for on-demand treatment of bleeding episodes in hemophilia B: analysis of pivotal trial data.

Authors:  Miguel A Escobar; Christopher E Walsh; David L Cooper; Guy Young
Journal:  J Blood Med       Date:  2019-07-25

4.  Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study.

Authors:  Tyler W Buckner; Robert Sidonio; Michelle Witkop; Christine Guelcher; Susan Cutter; Neeraj N Iyer; David L Cooper
Journal:  Patient Relat Outcome Meas       Date:  2019-09-18

Review 5.  How to discuss gene therapy for haemophilia? A patient and physician perspective.

Authors:  Wolfgang Miesbach; Brian O'Mahony; Nigel S Key; Mike Makris
Journal:  Haemophilia       Date:  2019-05-21       Impact factor: 4.287

Review 6.  The lived experience of women with a bleeding disorder: A systematic review.

Authors:  Anna Sanigorska; Steve Chaplin; Mike Holland; Kate Khair; Debra Pollard
Journal:  Res Pract Thromb Haemost       Date:  2022-02-03

7.  Shortening the Haemophilia Activities List (HAL) from 42 items to 18 items.

Authors:  Isolde A R Kuijlaars; Janjaap van der Net; Tyler W Buckner; Christine L Kempton; Roger E G Schutgens; Kathelijn Fischer
Journal:  Haemophilia       Date:  2021-09-08       Impact factor: 4.263

8.  Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.

Authors:  Erik Berntorp; Petra LeBeau; Margaret V Ragni; Munira Borhany; Yasmina L Abajas; Michael D Tarantino; Katharina Holstein; Stacy E Croteau; Raina Liesner; Cristina Tarango; Manuela Carvalho; Catherine McGuinn; Eva Funding; Christine L Kempton; Christoph Bidlingmaier; Alice Cohen; Johannes Oldenburg; Susan Kearney; Christine Knoll; Philip Kuriakose; Suchitra Acharya; Ulrike M Reiss; Roshni Kulkarni; Michelle Witkop; Stefan Lethagen; Rebecca Krouse; Amy D Shapiro; Jan Astermark
Journal:  Haemophilia       Date:  2022-03-08       Impact factor: 4.263

9.  Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.

Authors:  Ting Zhou; Haijing Guan; Luying Wang; Yao Zhang; Mingjun Rui; Aixia Ma
Journal:  Front Public Health       Date:  2021-06-29

Review 10.  Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.

Authors:  Benjamin J Samelson-Jones; Valder R Arruda
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.